Literature DB >> 1710958

DNA histogram debris theory and compensation.

C B Bagwell1, S W Mayo, S D Whetstone, S A Hitchcox, D R Baker, D J Herbert, D L Weaver, M A Jones, E J Lovett.   

Abstract

In this paper we describe a theory of DNA histogram debris generation and compensation that can be applied to paraffin-embedded frozen tissue preparations. The theory predicts the distribution of fragments generated from single and multiple random sectioning of three-dimensional ellipsoids representing nuclei. The fragment distribution is assumed to be a major component of the underlying debris in DNA histograms. A comparison of S-phase fractions (SPF) from matched tissue prepared by frozen and formalin-fixed paraffin-embedded DNA methods demonstrates the usefulness of the theory.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710958     DOI: 10.1002/cyto.990120203

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  4 in total

1.  S-phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence.

Authors:  S Wingren; O Stål; J Carstensen; X F Sun; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

2.  Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

Authors:  P Dettmar; N Harbeck; C Thomssen; L Pache; P Ziffer; K Fizi; F Jänicke; W Nathrath; M Schmitt; H Graeff; H Höfler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma.

Authors:  P Gustafson; B Baldetorp; M Fernö; M Akerman
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

4.  Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.

Authors:  N Harbeck; P Dettmar; C Thomssen; U Berger; K Ulm; R Kates; H Höfler; F Jänicke; H Graeff; M Schmitt
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.